Morgan Stanley lowered the firm’s price target on Marsh McLennan (MRSH) to $180 from $190 and keeps an Equal Weight rating on the shares. Most property and casualty insurance companies saw slower premium growth, but substantial underwriting profit in Q1, notes the analyst, who expects pricing and premiums to further deteriorate. The firm adjusted targets for the group following the Q1 earnings season.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRSH:
- Marsh McLennan upgraded to Buy from Neutral at Citi
- Marsh McLennan’s Oliver Wyman enters agreement to acquire CR3 Partners
- Marsh McLennan to acquire TriBridge Partners, terms not disclosed
- Marsh McLennan enters multiyear partnership with Formula 1
- Marsh McLennan price target raised to $203 from $200 at Keefe Bruyette